Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain-Training exercise games aim to stop Parkinson's falls

NCT ID NCT05986643

Recruiting now Symptom relief Sponsor: University of Leicester Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether combining exercise video games (exergaming) with real-time brainwave feedback can improve balance in people with Parkinson's disease. One hundred participants will be randomly assigned to either exergaming alone or exergaming plus neurofeedback, training three times a week for 12 weeks. The goal is to see if this approach reduces falls and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Exergaming with neurofeedback (EEG-based brainwave training)
What this could lead to
If it works, this could offer a new, non-drug way to improve balance and reduce falls in people with Parkinson's, potentially improving quality of life.
What could go wrong
This is an early-stage trial with only 100 participants, and it's testing a novel combination of exercise and brain feedback. The results may not apply to all people with Parkinson's, and the benefit may be small or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • University of Leicester

    RECRUITING

    Leicester, LE1 7RH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.